Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
1(33.3%)
N/A
1(33.3%)
Phase 1
1(33.3%)
3Total
Phase 3(1)
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05092399Completed

Effects of VLCD and Bariatric Surgery in Patients With Type 2 Diabetes

Role: collaborator

NCT01442766Phase 1Withdrawn

Donepezil Trial for Motor Recovery in Acute Stroke

Role: collaborator

NCT04281953Completed

Impact on Quality of Life of Long-term Ototoxicity in Cancer Survivors

Role: collaborator

NCT04270916Suspended

Prevalence and Impact on QoL From Ototoxicity in Cancer Survivors

Role: collaborator

NCT00348413Not ApplicableCompleted

Thyroid Treatment Trial

Role: collaborator

NCT00346450Phase 3Completed

Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation

Role: collaborator

All 6 trials loaded